Roth Capital analyst, David Solomon, reiterated his Neutral rating on shares of Apollo Endosurgery (NASDAQ: APEN) and cut his price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE